DPDawn Phillips

Dawn Phillips

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Dawn Phillips has a total of 37 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Characteristics associated with frequent sexually transmitted infection (STI) testing in a community-based sample of gay, bisexual, and other men who have sex with men (GBMSM), United Kingdom, 2024

    by Lucy Findlater, George Baldry, Ana K. Harb, Dolores Mullen, Dawn Phillips, Erna Buitendam, Catherine M. Lowndes, David Reid, Catherine H. Mercer, John Saunders, et al.

    In the UK, gay, bisexual, and other men who have sex with men (GBMSM) at risk of sexually transmitted infections (STIs) are recommended quarterly testing, but it is not known how many are following this recommendation. We described prevalence and correlates of frequent STI testing amongst GBMSM. We analysed data from the community-based Reducing Inequalities in Sexual Health (RiiSH) online survey of GBMSM, with recruitment in November-December 2024 via social media and dating apps. Participants were UK residents aged ≥16 years reporting sex with a man in the previous year. We described frequency of STI testing amongst individuals recommended quarterly testing, using proxies for national guidelines for quarterly testing eligibility (over the past three months: new male sexual partner, condomless anal sex, ≥ 10 male partners, or chemsex). We explored factors associated with frequent testing (≥4 tests/past year) using univariate and multivariable logistic regression, adjusting for country of birth and residence, ethnicity, employment, and education. Among 2758 participants (median age 45 years, 88% white), we estimated 2366 (86%) would be recommended quarterly STI testing. Among 2342 with testing information, 562 individuals (24%) met or exceeded this recommendation (≥4 tests), 1107 (47%) had 1–3 tests, and 673 (29%) none. Factors associated with frequent testing were: reporting using HIV-PrEP in the past year (adjusted odds ratio 7.66 (95% confidence intervals 5.77-10.30)), STI diagnosis in the past three months (1.96 (1.45-2.64)), and younger age (1.50 (1.04-2.16), 16–29 years vs ≥ 45 years). Straight/bisexual orientation was associated with less frequent testing than gay/homosexual (0.71 (0.52-0.96)). Overall, data from a large UK community survey suggest only 1 in 4 GBMSM who are recommended quarterly STI testing meet this recommendation, and testing levels vary by HIV-PrEP use, STI history, age, and sexual orientation. These findings provide baseline data for consideration in any updates to STI testing guidelines.


  • Open Access

    Characteristics associated with frequent sexually transmitted infection (STI) testing in a community-based sample of gay, bisexual, and other men who have sex with men (GBMSM), United Kingdom, 2024

    by Lucy Findlater, George Baldry, Ana K. Harb, Dolores Mullen, Dawn Phillips, Erna Buitendam, Catherine M. Lowndes, David Reid, Catherine H. Mercer, John Saunders, et al.

    In the UK, gay, bisexual, and other men who have sex with men (GBMSM) at risk of sexually transmitted infections (STIs) are recommended quarterly testing, but it is not known how many are following this recommendation. We described the prevalence and correlates of frequent STI testing amongst GBMSM. We analysed data on participants of the community-based Reducing Inequalities in Sexual Health (RiiSH) online survey of GBMSM, recruited in November-December 2024 via social media and dating apps. Participants were UK residents aged ≥16 years who reported sex with a man in the previous year. We described the frequency of STI testing amongst individuals recommended quarterly testing, using proxies for national guidelines for quarterly testing eligibility (over the past three months: new male sexual partner, condomless anal sex, ≥10 male partners, or chemsex). We explored factors associated with frequent testing (≥4 tests/past year) using univariate and multivariable logistic regression, adjusting for country of birth and residence, ethnicity, employment, and education. Among 2758 participants (median age 45 years, 88% white), we estimated that 2366 (86%) would be recommended quarterly STI testing. Over the past year, 562 individuals (24%) met or exceeded this recommendation (testing ≥4 times), 1107 (47%) had 1-3 tests, and 673 (28%) no tests. Factors associated with frequent testing were: reporting using PrEP in the past year (adjusted odds ratio 7.66 (95% confidence intervals 5.77-10.30)), STI diagnosis in the past three months (1.96 (1.45-2.64)), and younger age (1.50 (1.04-2.16), aged 16-29 years vs ≥45 years). Straight/bisexual orientation was associated with less frequent testing than gay/homosexual (0.71 (0.52-0.96)). Overall, data from a large UK community survey suggest that only 1 in 4 GBMSM who are recommended frequent STI testing meet this recommendation, and testing levels vary by PrEP use, STI history, age, and sexual orientation. Interventions are needed to address these inequalities.

  • Open Access

    The waiting room: unmet sexual health service needs among men and gender-diverse individuals having sex with men in England, findings from an online, cross-sectional community survey in 2024

    by Dana Ogaz, Dolores Mullen, George Baldry, Danielle Jayes, Dawn Phillips, Catherine M Lowndes, David Reid, Jordan Charlesworth, Erna Buitendam, David Phillips, et al.

    Background Sexual health service (SHS) delivery in England has shifted substantially following a rapid expansion of online services during the COVID-19 pandemic. While digital provision may improve reach, there are limited data on the extent of unmet need for in-person SHS in England. We sought to address this among men and gender-diverse individuals who have sex with men in England, a group disproportionately affected by sexual health inequalities. Methods We analysed data from “Reducing inequalities in Sexual Health” (RiiSH) 2024 (Nov/Dec 2024), an online cross-sectional survey of men and gender-diverse individuals who have sex with men residing in England. We assessed in-person SHS access and among those who tried to access a SHS in the last year - unmet need (i.e. participants who tried but were unable to access a SHS in-person) alongside reasons for inaccessibility. Using multivariable logistic regression, we examined sociodemographic and behavioural associations with unmet SHS need. Results Among 2,404 participants living in England (median age 45 years [interquartile range: 36-55], 88% White, 95% cisgender), 86% reported accessing in-person SHS ever, and 59% in the past year. Of those who tried to access in-person care in the past year, 12% (95% CI: 11%-14%) experienced unmet need, especially Outside London (15% vs. 8% in London). Common barriers included unavailable (50%) or inconvenient (41%) appointment times. In adjusted multivariable analysis, unmet need continued to be lower among participants living in London (aOR: 0.64 [95% CI: 0.44-0.92]), those financially comfortable (aOR: 0.69 [0.49-0.97]), and those reporting ≥1 marker(s) of sexual risk (e.g. HIV-PrEP use in the last year and/or in the last 3-4 months, the report of a bacterial STI diagnosis, engaging in chemsex, having had ≥10 male physical sex partners; aOR: 0.14 [0.10-0.20]). Unmet need was higher among participants with limiting long-term physical health conditions (aOR: 1.61 [1.12-2.30]) and those who reported ever using online postal self-sampling services for STI testing (OPSS) (aOR: 1.50 [1.07-2.09]). Conclusions Despite high SHS engagement, one in ten participants in this national community-based sample reported recent unmet need for in-person SHS. Equity-focused strategies are needed to meet evolving SHS demand. Local service delivery guided by joint strategic needs assessments could help address unmet need for SHS. Ethical considerations Ethical approval of this study was provided by the UKHSA Research and Ethics Governance Group (REGG; ref: R&D 524). Consent to participate Online informed consent was received from all participants and all methods were performed in accordance with guidelines and regulations set by the UKHSA REGG. Declaration of conflicting interest Authors have no conflicting interests to declare. Funding statement The RiiSH 2024 study and authors HM, JS, DR, CHM received partial funding support as part of The National Institute for Health Research Health Protection Research Unit in Blood Borne and Sexually Transmitted Infections at University College London in partnership with the UK Health Security Agency (https://bbsti.hpru.nihr.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All other authors received no specific funding for this work. Data availability The data that support the findings of this study are not publicly available to protect participant privacy. However, some aggregate data are available upon reasonable request from the UK Health Security Agency (UKHSA). Requests can be directed to DataAccess{at}ukhsa.gov.uk .


  • Open Access

    Knowledge, uptake and intention to use antibiotic post-exposure prophylaxis and meningococcal B vaccine (4CMenB) for gonorrhoea among a large, online community sample of men and gender-diverse individuals who have sex with men in the UK

    by Dana Ogaz, Jessica Edney, Dawn Phillips, Dolores Mullen, David Reid, Ruth Wilkie, Erna Buitendam, James Bell, Catherine M. Lowndes, Gwenda Hughes, et al.

    Novel STI prevention interventions, including doxycycline post-exposure prophylaxis (doxyPEP) and meningococcal B vaccination (4CMenB) against gonorrhoea, have been increasingly examined as tools to aid STI control. There is evidence of the efficacy of doxyPEP in preventing bacterial STIs; however, limited data exist on the extent of use in the UK. We examined self-reported knowledge and use of antibiotic post-exposure prophylaxis (PEP), and intention to use (ITU) doxyPEP and 4CMenB among a large, community sample of men and gender-diverse individuals who have sex with men in the UK. Using data collected by the RiiSH survey (November/December 2023), part of a series of online surveys of men and other gender-diverse individuals in the UK, we describe (%, [95% CI]) self-reported knowledge and use of antibiotic PEP (including doxyPEP) and doxyPEP and 4CMenB ITU. Using bivariate and multivariable logistic regression, we examined correlates of ever using antibiotic PEP, doxyPEP ITU, and 4CMenB ITU, respectively, adjusting for sociodemographic characteristics and a composite marker of sexual risk defined as reporting (in the last three months): ≥5 condomless anal sex partners, bacterial STI diagnosis, chemsex, and/or meeting partners at sex-on-premises venues, sex parties, or cruising locations. Of 1,106 participants (median age: 44 years [IQR: 34–54]), 34% (30%-37%) knew of antibiotic PEP; 8% (6%-10%) ever reported antibiotic PEP use. Among those who did, most reported use in the last year (84%, 73/87) and exclusively used doxycycline (69%, 60/87). Over half of participants reported doxyPEP ITU (51% [95% CI: 47%-56%], 568/1,106) while over two-thirds (64% [95% CI: 60%-69%], 713/1,106) reported 4CMenB ITU. Participants with markers of sexual risk and with uptake of other preventative interventions were more likely to report ever using antibiotic PEP as well as doxyPEP and 4CMenB ITU, respectively. HIV-PrEP users and people living with HIV (PLWHIV) were more likely to report antibiotic PEP use and doxyPEP and 4CMenB vaccination ITU than HIV-negative participants not reporting recent HIV-PrEP use. Findings demonstrate considerable interest in the use of novel STI prevention interventions, more so for 4CMenB vaccination relative to doxyPEP. Fewer than one in ten participants had reported ever using antibiotic PEP, with most using appropriate, evidence-based antibiotics. The use of antibiotic PEP and the report of doxyPEP ITU and 4CMenB ITU was more common among those at greater risk of STIs.


  • Open Access

    Mpox vaccination uptake in a UK community sample of gay, bisexual, and other men who have sex with men (GBMSM) the year following the 2022 Clade IIb mpox outbreak

    by Dolores Mullen, Jessica Edney, Dawn Phillips, Ruth Wilkie, David Reid, Catherine M Lowndes, Erna Buitendam, Katy Sinka, Sema Mandal, Catherine H Mercer, et al.

    Mpox is an infectious disease transmitted through close contact. It is caused by the monkeypox virus, which is endemic to some countries of West and Central Africa. A multi-country outbreak of mpox occurred in 2022, and the UK experienced rapid community transmission associated with sexual contact, mainly, but not exclusively among networks of gay, bisexual, and other men who have sex with men (GBMSM). In response to the outbreak in the UK, a reactive mpox vaccination programme was targeted to those most at risk. We explore the uptake and course completion of mpox vaccination in GBMSM taking part in an online survey in 2023. Findings from this community sample indicate vaccination uptake in around two-thirds of participants meeting mpox proxy eligibility criteria with high levels of course completion among all and eligible participants that were ever vaccinated. Vaccine non-offer was a barrier to uptake, as nearly a third of those eligible but unvaccinated reported never having received an mpox vaccine offer. Continued targeting of vaccination to GBMSM at highest risk of mpox at SHS, with community-support, will help facilitate equitable uptake of vaccination.

  • Open Access

    Knowledge, uptake and intention to use antibiotic post-exposure prophylaxis and meningococcal B vaccine (4CMenB) for gonorrhoea among a large, online community sample of gay, bisexual and other men who have sex with men in the UK

    by Dana Ogaz, Jessica Edney, Dawn Phillips, Dolores Mullen, David Reid, Ruth Wilkie, Erna Buitendam, James Bell, Catherine M Lowndes, Gwenda Hughes, et al.

    Introduction Novel STI prevention interventions, including doxycycline post-exposure prophylaxis (doxyPEP) and meningococcal B vaccination (4CMenB) against gonorrhoea, have been increasingly examined as tools to aid STI control. There is emerging evidence of the efficacy of doxyPEP in preventing bacterial STIs; however limited data exist on the extent of use in the UK. We examined self-reported knowledge and use of antibiotic post-exposure prophylaxis (PEP), and intention to use (ITU) doxyPEP and 4CMenB among a large, community sample of gay, bisexual and other men who have sex with men (GBMSM) in the UK. Methods Using data collected by the RiiSH survey (November/December 2023), part of a series of online surveys of GBMSM in the UK, we describe (%, [95% CI]) self-reported knowledge and use of antibiotic PEP (including doxyPEP) and doxyPEP and 4CMenB ITU. Using bivariate and multivariable logistic regression, we examined correlates of ever using antibiotic PEP, doxyPEP ITU, and 4CMenB ITU, respectively, adjusting for sociodemographic characteristics and a composite marker of sexual risk defined as reporting (in the last three months): ≥5 condomless anal sex partners, bacterial STI diagnosis, chemsex, and/or meeting partners at sex-on-premises venues, sex parties, or cruising locations. Results Of 1,106 participants (median age: 44 years [IQR: 34-54]), 34% (30%-37%) knew of antibiotic PEP; 8% (6%-10%) ever reported antibiotic PEP use. Among those who did, most reported use in the last year (84%, 73/87) and exclusively used doxycycline (69%, 60/87). Over half of participants reported doxyPEP ITU (51% [47%-56%]) while over two-thirds (64% [60%-69%]) reported 4CMenB ITU. GBMSM with markers of sexual risk and with uptake of other preventative interventions were more likely to report ever using antibiotic PEP as well as doxyPEP and 4CMenB ITU, respectively. HIV-PrEP users and people living with HIV (PLWHIV) were more likely to report STI prophylaxis use and ITU than HIV-negative GBMSM not reporting recent HIV-PrEP use. Discussion There were high levels of intended use of novel STI prevention interventions. Fewer than one in ten GBMSM had reported ever using antibiotic PEP, with usage more common among those at greater risk of STIs. Future guidelines and health promotion for 4CMenB and antibiotic PEP must be carefully crafted alongside clinical experts and community partners, given intervention complexity and the risk of presenting conflicting public health messages regarding antimicrobial stewardship.


  • Open Access

    Factors associated with human papillomavirus, hepatitis A, hepatitis B and mpox vaccination uptake among gay, bisexual and other men who have sex with men in the UK – findings from the large community-based RiiSH-Mpox survey

    by George Baldry, Dawn Phillips, Ruth Wilkie, Marta Checchi, Kate Folkard, Ruth Simmons, John Saunders, Sema Mandal, Catherine H Mercer, Hamish Mohammed, et al.

    Background Gay, bisexual, and other men who have sex with men (GBMSM) face a disproportionate burden of sexually transmitted infections and are eligible for targeted vaccinations for hepatitis A (HAV), hepatitis B (HBV), human papilloma virus (HPV) and mpox. This study examines the sociodemographic characteristics, sexual behaviours, and sexual healthcare service (SHS) use associated with vaccination uptake. Methods We undertook analyses of RiiSH-Mpox - an online, community-based survey with GBMSM recruited via social media and dating apps. We calculated vaccination uptake (≥1 dose) among eligible GBMSM. Bivariate and multivariable logistic regression was performed to identify factors independently associated with vaccination uptake among eligible participants. Results Reported uptake in eligible GBMSM was around two-thirds for each of the vaccinations considered: mpox 69% (95% confidence interval (CI): 66%-72%), HAV 68% (CI:65%-70%), HBV 72% (CI:69%-74%) and HPV 65% (CI:61%-68%). Vaccination course completion (receiving all recommended doses) ranged from 75% (HBV) to 89% (HAV) among eligible GBMSM. Individuals who represented missed opportunities for vaccination ranged from 22-30% of eligible SHS attendees. Younger participants, individuals identifying as bisexual, reporting lower educational qualifications, or being unemployed reported lower uptake across GBMSM-selective vaccinations. Individuals who reported greater levels of sexual behaviour and recent SHS use were more likely to report vaccinations. Conclusion Eligible participants reported high uptake of vaccinations; however, uptake was lower amongst young GBMSM and self-identifying bisexual men. Awareness of groups with lower vaccination uptake will help inform practice, delivery strategies and health promotion, to improve the reach and impact of vaccinations amongst GBMSM. Contributions DP, RW, KF, CHM, JS, HM reviewed and updated the survey instrument. Survey implementation, data collection and data management were carried out by RW and DO. GB, CM, DO, HM curated secondary analysis plan with review and contributions from KF, MC, JS, RS, SM. GB conducted analysis and completed the first manuscript draft. All authors contributed to successive drafts and reviewed and approved the final manuscript. Ethics statement Ethical approval of this study was provided by the UKHSA Research and Ethics Governance Group (REGG; ref: R&D 524). Online informed consent was received from all participants and all methods were performed in accordance with guidelines and regulations set by the UKHSA REGG. Competing interests Authors have no competing interests to declare. Data availability statement The data that support the findings of this study are available upon reasonable request from the UK Health Security Agency (UKHSA). Requests can be directed to Dr Hamish Mohammed ( hamish.mohammed{at}ukhsa.gov.uk ). Funding This study did not receive any funding and was conducted as part of the UKHSA public health response to mpox.


  • Open Access

    Mpox diagnosis history, behavioural risk modification, and vaccination uptake in gay, bisexual, and other men who have sex with men in the UK: findings from a large, online community cross-sectional survey (RiiSH-Mpox) undertaken November/December 2022

    by Dana Ogaz, Qudsia Enayat, Jack Rg Brown, Dawn Phillips, Ruth Wilkie, Danielle Jayes, David Reid, Gwenda Hughes, Catherine H Mercer, John Saunders, et al.

    Mpox cases, first identified as part of the multi-country outbreak in May 2022, rapidly fell in the UK from September 2022. Public health responses included community-coordinated messaging and a targeted mpox vaccination in eligible gay, bisexual, and other men who have sex with men (GBMSM). Using data from an online, community survey of GBMSM (November/December 2022), we examined self-reported mpox diagnoses, behavioural risk modification, and mpox vaccination offer and uptake (≥1 dose). Thirty-five participants (2.6%, 35/1,333) were ever mpox test positive; half (53%, 707/1,333) reported behaviour modification to avoid mpox. In GBMSM considered vaccine eligible, uptake was 69% (95% CI: 65%-72%, 601/875) or 92% (95% CI: 89%-94%, 601/655) in those eligible and offered. GBMSM self-identifying as bisexual, those with lower educational qualifications, and those unemployed were less likely to be vaccinated. Equitable mpox vaccine offer and provision is needed to minimise the risk of future outbreaks and mpox-related health inequalities.